20/06/2026
The research presents an innovative microsponge-based gel formulation of Halobetasol Propionate for psoriasis treatment, offering controlled drug release, enhanced skin permeation, improved therapeutic efficacy, and better patient compliance. The optimized formulation demonstrated excellent encapsulation efficiency, stability, and superior performance compared to conventional marketed formulations.
This achievement reflects Monark Universityโs commitment to impactful healthcare research and pharmaceutical innovation.
Heartiest congratulations to Ms. Seju Patel on this remarkable accomplishment. We wish her continued success in advancing scientific discovery and innovation.